1. Home
  2. CNDT vs DTIL Comparison

CNDT vs DTIL Comparison

Compare CNDT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.50

Market Cap

234.2M

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$6.70

Market Cap

197.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
DTIL
Founded
2016
2006
Country
United States
United States
Employees
51000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.2M
197.9M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
CNDT
DTIL
Price
$1.50
$6.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $29.40
AVG Volume (30 Days)
★ 915.3K
219.2K
Earning Date
11-06-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $3,042,000,000.00
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.15
$3.53
52 Week High
$2.63
$9.62

Technical Indicators

Market Signals
Indicator
CNDT
DTIL
Relative Strength Index (RSI) 44.95 53.58
Support Level $1.31 $6.62
Resistance Level $1.62 $6.92
Average True Range (ATR) 0.08 0.38
MACD -0.01 0.09
Stochastic Oscillator 37.50 81.74

Price Performance

Historical Comparison
CNDT
DTIL

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: